Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Fish and Richardson
Harvard Business School
US Army
McKesson
Baxter

Generated: May 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,548,078

« Back to Dashboard

Summary for Patent: 6,548,078
Title: Method for treating and/or preventing retinal diseases with sustained release corticosteroids
Abstract:The present invention relates to a method for administering a corticosteroid to a posterior segment of an eye. In the method, a sustained release device is implanted to deliver the corticosteroid to the eye. The aqueous corticosteroid concentration remains less than vitreous corticosteroid concentration during release of the corticosteroid from the device.
Inventor(s): Guo; Hong (Belmont, MA), Ashton; Paul (Boston, MA)
Assignee: Control Delivery Systems (Watertown, MA)
Application Number:09/735,636
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 6,548,078
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 6,548,078

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alimera Sciences Inc ILUVIEN fluocinolone acetonide IMPLANT;INTRAVITREAL 201923-001 Sep 26, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF DIABETIC MACULAR EDEMA ➤ Sign Up
Bausch And Lomb RETISERT fluocinolone acetonide IMPLANT;INTRAVITREAL 021737-001 Apr 8, 2005 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE ➤ Sign Up
Eyepoint Pharms YUTIQ fluocinolone acetonide IMPLANT;INTRAVITREAL 210331-001 Oct 12, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF CHRONIC NON-INFECTIOUS UVEITIS AFFECTING THE POSTERIOR SEGMENT OF THE EYE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 6,548,078

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2005200243 ➤ Sign Up
Australia 4174800 ➤ Sign Up
Australia 777727 ➤ Sign Up
Brazil 0010869 ➤ Sign Up
Canada 2367092 ➤ Sign Up
European Patent Office 1162978 ➤ Sign Up
Japan 2002539263 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Julphar
Farmers Insurance
Chubb
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.